B

Bio-Gene Technology Ltd
ASX:BGT

Watchlist Manager
Bio-Gene Technology Ltd
ASX:BGT
Watchlist
Price: 0.033 AUD -2.94% Market Closed
Market Cap: AU$10.1m

Cash Flow Statement

Cash Flow Statement
Bio-Gene Technology Ltd

Rotate your device to view
Cash Flow Statement
Currency: AUD
Jun-2018 Jun-2019 Dec-2019 Jun-2020 Dec-2020 Jun-2021 Dec-2021 Jun-2022 Dec-2022 Jun-2023 Dec-2023 Jun-2024 Dec-2024 Jun-2025
Operating Cash Flow
Stock-Based Compensation
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Cash Taxes Paid
0
0
0
1
1
0
0
1
1
0
0
1
1
1
Cash Interest Paid
0
0
(0)
(0)
(0)
(0)
(0)
0
0
0
0
0
0
0
Change in Working Capital
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Cash from Operating Activities
(2)
N/A
(2)
+7%
(1)
+61%
(2)
-92%
(1)
+22%
(2)
-43%
(2)
-31%
(2)
+17%
(3)
-51%
(3)
-9%
(3)
+10%
(3)
+6%
(2)
+32%
(3)
-35%
Investing Cash Flow
Capital Expenditures
(0)
(0)
0
0
0
(0)
(0)
(0)
(0)
0
(0)
(0)
(0)
0
Other Items
(0)
(0)
0
0
0
0
0
0
0
0
0
0
0
0
Cash from Investing Activities
(0)
N/A
(0)
+98%
0
N/A
0
N/A
0
N/A
(0)
N/A
(0)
N/A
(0)
-127%
(0)
N/A
0
N/A
0
N/A
(0)
N/A
(0)
-42%
0
N/A
Financing Cash Flow
Net Issuance of Common Stock
7
0
0
3
3
0
3
5
2
0
2
2
0
1
Net Issuance of Debt
0
0
(0)
(0)
(0)
(0)
(0)
(0)
0
(0)
(0)
0
0
0
Other
(1)
0
0
(0)
(0)
(0)
(0)
(0)
(0)
0
(0)
(0)
0
(0)
Cash from Financing Activities
7
N/A
0
-100%
(0)
N/A
3
N/A
3
-1%
0
-91%
3
+1 239%
4
+37%
1
-67%
(0)
N/A
2
N/A
2
+4%
0
N/A
1
N/A
Change in Cash
Net Change in Cash
4
N/A
(2)
N/A
(1)
+61%
1
N/A
1
+34%
(2)
N/A
1
N/A
2
+197%
(2)
N/A
(3)
-115%
(1)
+69%
(1)
+24%
(2)
-142%
(1)
+43%
Free Cash Flow
Free Cash Flow
(3)
N/A
(2)
+16%
(1)
+61%
(2)
-92%
(1)
+22%
(2)
-43%
(2)
-31%
(2)
+17%
(3)
-51%
(3)
-8%
(3)
+10%
(3)
+6%
(2)
+32%
(3)
-35%
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett